Randomized, Prospective Trial of Antioxidant Supplementation in Critically Ill Surgical Patients

ObjectiveTo determine the effectiveness of early, routine antioxidant supplementation using &agr;-tocopherol and ascorbic acid in reducing the rate of pulmonary morbidity and organ dysfunction in critically ill surgical patients. Summary Background DataOxidative stress has been associated with the development of the acute respiratory distress syndrome (ARDS) and organ failure through direct tissue injury and activation of genes integral to the inflammatory response. In addition, depletion of endogenous antioxidants has been associated with an increased risk of nosocomial infections. The authors postulated that antioxidant supplementation in critically ill surgical patients may reduce the incidence of ARDS, pneumonia, and organ dysfunction. MethodsThis randomized, prospective study was conducted to compare outcomes in patients receiving antioxidant supplementation (&agr;-tocopherol and ascorbate) versus those receiving standard care. The primary endpoint for analysis was pulmonary morbidity (a composite measure of ARDS and nosocomial pneumonia). Secondary endpoints included the development of multiple organ failure, duration of mechanical ventilation, length of ICU stay, and mortality. ResultsFive hundred ninety-five patients were enrolled and analyzed, 91% of whom were victims of trauma. The relative risk of pulmonary morbidity was 0.81 (95% confidence interval 0.60–1.1) in patients receiving antioxidant supplementation. Multiple organ failure was significantly less likely to occur in patients receiving antioxidants than in patients receiving standard care, with a relative risk of 0.43 (95% confidence interval 0.19–0.96). Patients randomized to antioxidant supplementation also had a shorter duration of mechanical ventilation and length of ICU stay. ConclusionsThe early administration of antioxidant supplementation using &agr;-tocopherol and ascorbic acid reduces the incidence of organ failure and shortens ICU length of stay in this cohort of critically ill surgical patients.

[1]  W. Helton,et al.  Enteral vitamin E supplementation inhibits the cytokine response to endotoxin. , 1997, Archives of surgery.

[2]  A. Sauaia,et al.  Early predictors of postinjury multiple organ failure. , 1994, Archives of surgery.

[3]  R. Ivatury,et al.  Antioxidant Therapy in the Prevention of Organ Dysfunction Syndrome and Infectious Complications after Trauma: Early Results of a Prospective Randomized Study , 1999, The American surgeon.

[4]  H. Hemilä.  Vitamin C intake and susceptibility to pneumonia. , 1997, The Pediatric infectious disease journal.

[5]  T. Evans,et al.  Plasma fatty acid changes and increased lipid peroxidation in patients with adult respiratory distress syndrome. , 1996, Critical care medicine.

[6]  K. Steinberg,et al.  Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome. , 1994, American journal of respiratory and critical care medicine.

[7]  C. Sprung,et al.  Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. , 1995, Critical care medicine.

[8]  E. Abraham,et al.  Xanthine oxidase-derived oxygen radicals increase lung cytokine expression in mice subjected to hemorrhagic shock. , 1995, American journal of respiratory cell and molecular biology.

[9]  A. Nathens,et al.  N‐ACETYL CYSTEINE ATTENUATES ACUTE LUNG INJURY IN THE RAT , 1995, Shock.

[10]  K. Steinberg,et al.  Safety of bronchoalveolar lavage in patients with adult respiratory distress syndrome. , 1993, The American review of respiratory disease.

[11]  R. Strieter,et al.  Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. , 1996, American journal of respiratory and critical care medicine.

[12]  J. Marshall,et al.  Pyrrolidine dithiocarbamate attenuates endotoxin-induced acute lung injury. , 1997, American journal of respiratory cell and molecular biology.

[13]  J. Morrow,et al.  Isoprostanes. Novel markers of endogenous lipid peroxidation and potential mediators of oxidant injury. , 1994, Annals of the New York Academy of Sciences.

[14]  J. Christman,et al.  In vivo antioxidant treatment suppresses nuclear factor-kappa B activation and neutrophilic lung inflammation. , 1996, Journal of immunology.

[15]  B. Christman,et al.  Exhaled breath condensate isoprostanes are elevated in patients with acute lung injury or ARDS. , 1998, Chest.

[16]  J. Repine,et al.  Circulating xanthine oxidase mediates lung neutrophil sequestration after intestinal ischemia-reperfusion. , 1992, The American journal of physiology.

[17]  B. P. Thompson.  N-acetylcysteine enhances recovery from acute lung injury in man , 1994 .

[18]  J. Blumberg,et al.  Vitamin E supplementation and in vivo immune response in healthy elderly subjects. A randomized controlled trial. , 1997, JAMA.

[19]  S. Orrenius,et al.  Triggering and modulation of apoptosis by oxidative stress. , 2000, Free radical biology & medicine.

[20]  D. Menon,et al.  Plasma antioxidant potential in severe sepsis: a comparison of survivors and nonsurvivors. , 1996, Critical care medicine.

[21]  G. Bernard,et al.  A trial of antioxidants N-acetylcysteine and procysteine in ARDS. The Antioxidant in ARDS Study Group. , 1997, Chest.

[22]  A. Malik,et al.  Hydrogen peroxide-induced increase in endothelial adhesiveness is dependent on ICAM-1 activation. , 1993, The American journal of physiology.

[23]  E. Pacht,et al.  Oxidized glutathione is increased in the alveolar fluid of patients with the adult respiratory distress syndrome. , 1993, The American review of respiratory disease.

[24]  G R Bernard,et al.  The American-European Consensus Conference on ARDS, part 2: Ventilatory, pharmacologic, supportive therapy, study design strategies, and issues related to recovery and remodeling. Acute respiratory distress syndrome. , 1998, American journal of respiratory and critical care medicine.

[25]  J. Pincemail,et al.  Differences in tocopherol-lipid ratios in ARDS and non-ARDS patients , 2004, Intensive Care Medicine.

[26]  P. Howdle,et al.  Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction. , 1995, Critical care medicine.

[27]  P. Herlevsen,et al.  Antioxidant treatment with N‐acetylcysteine during adult respiratory distress syndrome: A prospective, randomized, placebo‐controlled study , 1992, Critical care medicine.

[28]  C. Weber,et al.  Pyrrolidine dithiocarbamate inhibits NF-kappa B mobilization and TNF production in human monocytes. , 1993, Journal of immunology.

[29]  T. Koch,et al.  Antioxidant status in patients with acute respiratory distress syndrome , 1999, Intensive Care Medicine.

[30]  E. Maderazo,et al.  A randomized trial of replacement antioxidant vitamin therapy for neutrophil locomotory dysfunction in blunt trauma. , 1991, The Journal of trauma.

[31]  A. Bodenham,et al.  Total vitamin C, ascorbic acid, and dehydroascorbic acid concentrations in plasma of critically ill patients. , 1996, The American journal of clinical nutrition.

[32]  R. Shenkar,et al.  Nuclear factor-kappa B is activated in alveolar macrophages from patients with acute respiratory distress syndrome. , 1996, Critical care medicine.

[33]  L. Carbonell,et al.  Plasma redox status relates to severity in critically ill patients , 2000, Critical care medicine.

[34]  A. Diplock.  Safety of antioxidant vitamins and beta-carotene. , 1995, The American journal of clinical nutrition.

[35]  P. Suter,et al.  Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk. , 1996, Critical care medicine.

[36]  J. Repine,et al.  Effect of vitamin E deficiency and supercritical fluid aerosolized vitamin E supplementation on interleukin-1-induced oxidative lung injury in rats. , 1995, Free radical biology & medicine.

[37]  A. Nahum,et al.  Increased hydrogen peroxide in the expired breath of patients with acute hypoxemic respiratory failure. , 1989, Chest.